Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility

Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility

Author Toledo, Rodrigo A. Google Scholar
Hatakana, Roxanne Google Scholar
Lourenco, Delmar M. Google Scholar
Lindsey, Susan C. Autor UNIFESP Google Scholar
Camacho, Cleber P. Autor UNIFESP Google Scholar
Almeida, Marcio Google Scholar
Lima, Jose V. Google Scholar
Sekiya, Tomoko Google Scholar
Garralda, Elena Google Scholar
Naslavsky, Michel S. Google Scholar
Yamamoto, Guilherme L. Google Scholar
Lazar, Monize Google Scholar
Meirelles, Osorio Google Scholar
Sobreira, Tiago J. P. Google Scholar
Lebrao, Maria Lucia Google Scholar
Duarte, Yeda A. O. Google Scholar
Blangero, John Google Scholar
Zatz, Mayana Google Scholar
Cerutti, Janete M. Autor UNIFESP Google Scholar
Maciel, Rui M. B. Autor UNIFESP Google Scholar
Toledo, Sergio P. A. Autor UNIFESP Google Scholar
Institution Universidade de São Paulo (USP)
Universidade Federal de São Paulo (UNIFESP)
Brazilian Natl Lab Biosci
Hosp Univ Sanchinarro
AT&T Genom Comp Ctr
Santa Casa Hosp
NIA
Abstract Accurate interpretation of germline mutations of the rearranged during transfection (RET) proto-oncogene is vital for the proper recommendation of preventive thyroidectomy in medullary thyroid carcinoma (MTC)-prone carriers. To gain information regarding the most disputed variant of RET, ATA-A Y791F, we sequenced blood DNA samples from a cohort of 2904 cancer-free elderly individuals (1261 via Sanger sequencing and 1643 via whole-exome/genome sequencing). We also accessed the exome sequences of an additional 8069 individuals from non-cancer-related laboratories and public databanks as well as genetic results from the Catalogue of Somatic Mutations in Cancer (COSMIC) project. the mean allelic frequency observed in the controls was 0.0031, with higher occurrences in Central European populations (0.006/0.008). the prevalence of RET Y791F in the control databases was extremely high compared with the 40 known RET pathogenic mutations (P=0.00003), while no somatic occurrence has been reported in tumours. in this study, we report new, unrelated Brazilian individuals with germline RET Y791F-only: two tumour-free elderly controls; two individuals with sporadic MTC whose Y791F-carrying relatives did not show any evidence of tumours; and a 74-year-old phaeochromocytoma patient without MTC. Furthermore, we showed that the co-occurrence of Y791F with the strong RET C634Y mutation explains the aggressive MTC phenotypes observed in a large affected family that was initially reported as Y791F-only. Our literature review revealed that limited analyses have led to the misclassification of RET Y791F as a probable pathogenic variant and, consequently, to the occurrence of unnecessary thyroidectomies. the current study will have a substantial clinical influence, as it reveals, in a comprehensive manner, that RET Y791F only shows no association with MTC susceptibility.
Keywords multiple endocrine neoplasias
RET oncogene
MEN2
medullary thyroid carcinoma
genetics
Language English
Sponsor Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Grant number CNPq: 401.990/2010-9
FAPESP: 2013/01476-9
FAPESP: 2006/60402-1
FAPESP: 2010/51547-1
CAPES: 028/2013
Date 2015-02-01
Published in Endocrine-related Cancer. Bristol: Bioscientifica Ltd, v. 22, n. 1, p. 65-76, 2015.
ISSN 1351-0088 (Sherpa/Romeo, impact factor)
Publisher Bioscientifica Ltd
Extent 65-76
Origin http://dx.doi.org/10.1530/ERC-14-0491
Access rights Open access Open Access
Type Article
Web of Science ID WOS:000352002500015
URI http://repositorio.unifesp.br/handle/11600/38665

Show full item record




File

Name: WOS000352002500015.pdf
Size: 201.0Kb
Format: PDF
Description:
Open file

This item appears in the following Collection(s)

Search


Browse

Statistics

My Account